THIS AGREEMENT is made the day25th of November 2005. BETWEEN: THIS AGREEMENT is made the 25th day of November 2005. BETWEEN: PHARMANET GROUP LIMITED (ABN 98 006 640 553), of Level 1, 284 Oxford Street, Leederville, Western Australia ("Pharmanet"); AND...Agreement • January 31st, 2006 • Molecular Pharmacology (USA) LTD • Pharmaceutical preparations • Western Australia
Contract Type FiledJanuary 31st, 2006 Company Industry JurisdictionPharmanet is the legal and beneficial owner of the MPL Shares. Pharmanet has agreed to sell and MPLUSA has agreed to purchase the MPL Shares on the terms and conditions set out in this Agreement.
DISTRIBUTION AND SUPPLY AGREEMENT By and Between Molecular Pharmacology Limited (ACN 110 037 860) And: Molecular Pharmacology (USA) Limited DATED: OCTOBER 13, 2005Distribution and Supply Agreement • October 18th, 2005 • Molecular Pharmacology (USA) LTD • Gold and silver ores • Western Australia
Contract Type FiledOctober 18th, 2005 Company Industry JurisdictionMolecular Pharmacology Limited (ACN 110 037 860), a corporation duly organized and existing under the applicable laws of Australia, having an address at Level 1, 284 Oxford Street, Leederville, Western Australia ("MPL").
TRUST AGREEMENTTrust Agreement • January 23rd, 2003 • Blue Hawk Ventures Inc • British Columbia
Contract Type FiledJanuary 23rd, 2003 Company JurisdictionBLUE HAWK VENTURES, INC., a company duly incorporated under the laws of the State of Nevada and having an office at Unit 35, 12880 Railway Avenue, Richmond, B.C., V7E 6G4
OPTION TO PURCHASE AND ROYALTY AGREEMENTOption to Purchase and Royalty Agreement • January 23rd, 2003 • Blue Hawk Ventures Inc • British Columbia
Contract Type FiledJanuary 23rd, 2003 Company JurisdictionBYRON G. COX, Trustee for BLUE HAWK VENTURES INC., a company duly incorporated under the laws of the State of Nevada, having an office at Unit 35, 12880 Railway Avenue, Richmond, BC, V7E 6G4
DERMATOLOGY DEVELOPMENT CORPORATIONMolecular Pharmacology (USA) Ltd. • July 19th, 2013 • Pharmaceutical preparations
Company FiledJuly 19th, 2013 IndustryWe wish to confirm an agreement between Dermatology Development Corporation (DDC), a corporation organized under the laws of the State of New York, and Molecular Pharmacology Pty Ltd (MPL). This contract covers the potential royalties concerning the brokering by DDC (Services) of MPL USA's products and technology (Products and Technology) to potential partner and distribution companies in the United States of America (Territory).